Search
Wednesday 25 May 2016
  • :
  • :

Archives post

21

Technology Stock News Buzz: Acuity Brands, Inc. (NYSE:AYI)

On Monday, Shares of Acuity Brands, Inc. (NYSE:AYI) lost -1.22% to $252.90. The share price is trading in a range of 252.01 - 256.25...

Oil & GAS (6)

Basic Material Stock’s Traders Recap: Gulfmark Offshore, Inc. (NYSE:GLF)

On Monday, Shares of Gulfmark Offshore, Inc. (NYSE:GLF) lost -0.17% to $5.85. The share price is trading in a range of 5.73 - 6.33...

home6

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) is an Eye-Catching Stock

On Monday, Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) gained 0.41% to $31.91. The share price is trading in a range of 31.60...

business2

Worth Watching Technology Stock: QTS Realty Trust, (NYSE:QTS)

On Monday, Shares of QTS Realty Trust, Inc. (NYSE:QTS) lost -0.31% to $47.90. The share price is trading in a range of 47.62 - 48.21...

fsd

Technology Stock Celestica Inc. (NYSE:CLS) Earnings Result in Focus

On Thursday, Shares of Celestica Inc. (NYSE:CLS) gained 4.19% to $10.95. The 52-week range of the share price is from $8.07 – $13.49. The...

gfgdfgdf

Biotechnology Stock in the Spotlight: Quest Diagnostics Inc. (NYSE:DGX)

On Thursday, Shares of Quest Diagnostics Inc. (NYSE:DGX) gained 1.23% to $75.64. The 52-week range of the share price is from $59.66 –...

fafddsf

Financial Stock to Track: TCF Financial Corporation, (NYSE:TCB)

On Thursday, Shares of TCF Financial Corporation (NYSE:TCB) gained 0.90% to $13.41. The 52-week range of the share price is from $10.37 –...

Oil & GAS (6)

Basic Material Stock to Track: Enduro Royalty Trust (NYSE:NDRO)

On Tuesday, Shares of Enduro Royalty Trust (NYSE:NDRO) gained 0.30% to $3.36. The 52-week range of the share price is from $1.77 – $5.10....

RELM Wireless Corp.,

Technology Stock News Buzz: RELM Wireless Corp., (NYSEMKT:RWC)

On Tuesday, Shares of RELM Wireless Corp. (NYSEMKT:RWC), gained 1.01% to $4.8990. Trading volume recorded for this company is about 915...

slide

Biotechnology Stock News Review: Immunomedics Inc. (NASDAQ:IMMU)

Immunomedics, Inc. (NASDAQ:IMMU), a clinical-stage biopharmaceutical company, today declared that sacituzumab govitecan, its lead...